Last edition
News about "Kelly Sitkin"
US FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
The US Food and Drug Administration (FDA) has approved Telix’s Pixclara, the first FET-PET imaging drug for glioma, helping differentiate recurrent or progressive brain cancer from treatment-related changes.
Kelly Sitkin | 15/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members